ArticleMetabolomics : Official journal of the Metabolomic Society2025
A machine learning framework for classifying lipids in untargeted metabolomics using mass-to-charge ratios and retention times.
Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
introductionThe identification of unknown metabolites remains a major challenge in untargeted metabolomics using liquid chromatography-mass spectrometry (LC-MS). This process typically depends on comparing mass spectral or chromatographic data to reference databases or deciphering complex fragmentation in tandem mass spectra. While current machine learning methods can predict metabolite structures using MS/MS (MS2) data, no approaches, to our knowledge, use only mass-to-charge ratio (m/z) and retention time (RT) from LC-MS data.
objectiveTo explore the potential of using the mass-to-charge ratio (m/z) and retention time (RT) from LC-MS data as standalone predictors for metabolite classification and propose a modeling framework which can be implemented internally on standalone datasets.
methodsWe trained machine learning models on 20 mouse lung adenocarcinoma tumor samples with 7,353 features and validated them on a dataset of 81 samples with 22,000 features. A total of 120 combination of preprocessors and models were assessed. Features were classified as "lipid" or "non-lipid" based on the Human Metabolome Database (HMDB) taxonomy, and model performance was assessed using accuracy, area under the receiver operating characteristic curve (AUC), and area under the precision-recall curve (PR). We replicate the process in an independent dataset generated using human plasma samples.
resultsWe classified untargeted LC-MS features as "lipid" or "non-lipid" per the HMDB super class taxonomy and evaluated model performance. A framework including steps to choose the preprocessors and models for metabolite classification was designed. In our lab, tree-based models demonstrated superior performance across all metrics, achieving high accuracy, AUC, and PR which was consistent with the independent dataset.
conclusionOur results demonstrate that metabolites can be classified as "lipid", "non-lipid" using only m/z and RT from untargeted LC-MS data, without requiring MS2 spectra. Although this study focused on lipid classification, the approach shows potential for broader application, which warrants further investigation across diverse compound classes, detection methods, and chromatographic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.